Compare OPRA & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPRA | TNDM |
|---|---|---|
| Founded | 1996 | 2006 |
| Country | Norway | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2018 | 2013 |
| Metric | OPRA | TNDM |
|---|---|---|
| Price | $18.81 | $17.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 19 |
| Target Price | $21.50 | ★ $28.00 |
| AVG Volume (30 Days) | 378.3K | ★ 2.8M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,014,736,000.00 |
| Revenue This Year | $21.29 | $8.11 |
| Revenue Next Year | $15.34 | $11.85 |
| P/E Ratio | $13.62 | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $11.71 | $10.00 |
| 52 Week High | $21.06 | $29.65 |
| Indicator | OPRA | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 52.21 |
| Support Level | $13.08 | $11.86 |
| Resistance Level | $19.24 | $21.68 |
| Average True Range (ATR) | 0.58 | 1.11 |
| MACD | -0.03 | 0.39 |
| Stochastic Oscillator | 99.05 | 80.07 |
Opera Ltd is a consumer internet software company providing a diversified portfolio of high-performance web browsers and adjacent digital services to engaged user base The company has transitioned from browser developer to multi-faceted platform offering a products and services that include PC and mobile browsers, its Opera Gaming portals and development tools, Opera News content platforms, Opera Ads platform, as well as a number of AI and web3 products and services, such as MiniPay and Opera AI, to a user base.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.